Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection

Cytokine

Volumn 60, Issue 2, 2012, Pages 338-340

  Delaloye, Julie ^a   De Bruin, Irma J A ^a   Darling, Katharine E A ^a   Reymond, Marlies Knaup ^a   Sweep, Fred C G J ^b   Roger, Thierry ^a   Calandra, Thierry ^a   Cavassini, Matthias ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute HIV infection; Cytokines; HIV; Innate immunity; Macrophage migratory inhibitory factor

Indexed keywords

ANTIRETROVIRUS AGENT; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE STORM; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; VIRUS REPLICATION;

ACUTE DISEASE; ADULT; AGED; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84866761622     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.07.027     Document Type: Article

References (13)

1. Chang J.J., Altfeld M. Innate immune activation in primary HIV-1 infection. J Infect Dis 2010, 202(Suppl. 2):S297-S301.
2. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003, 3:791-800.
3. Calandra T., Froidevaux C., Martin C., Roger T. Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis. J Infect Dis 2003, 187(Suppl. 2):S385-S390.
4. Chen L.C., Lei H.Y., Liu C.C., Shiesh S.C., Chen S.H., Liu H.S., et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 2006, 74:142-147.
5. Zhang W., Yue B., Wang G.Q., Lu S.L. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat Dis Int 2002, 1:577-580.
6. Arjona A., Foellmer H.G., Town T., Leng L., McDonald C., Wang T., et al. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest 2007, 117:3059-3066.
7. Schoeni-Affolter F., Ledergerber B., Rickenbach M., Rudin C., Gunthard H.F., Telenti A., et al. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 2010, 39:1179-1189.
8. Radstake T.R., Sweep F.C., Welsing P., Franke B., Vermeulen S.H., Geurts-Moespot A., et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005, 52:3020-3029.
9. Mogensen T.H., Melchjorsen J., Larsen C.S., Paludan S.R. Innate immune recognition and activation during HIV infection. Retrovirology 2010, 7:54.
10. Regis E.G., Barreto-de-Souza V., Morgado M.G., Bozza M.T., Leng L., Bucala R., et al. Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication. Virology 2010, 399:31-38.
11. Mitchell R.A. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 2004, 16:13-19.
12. Kibiki G.S., van der Ven A.J., Geurts-Moespot A., Shao J., Calandra T., Sweep F.C., et al. Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases. Clin Immunol 2007, 123:60-65.
13. Watanabe D., Uehira T., Yonemoto H., Bando H., Ogawa Y., Yajima K., et al. Sustained high levels of serum interferon-gamma during HIV-1 infection: a specific trend different from other cytokines. Viral Immunol 2010, 23:619-625.